Indigo

Indigo, clinically known as Indigotindisulfonate Sodium, is a diagnostic dye used primarily to assess kidney function and visualize the urinary tract during surgical procedures. It belongs to the class of diagnostic radiopaque agents and biological dyes.

The standard adult dose of Indigo (Indigotindisulfonate Sodium) is generally 40 mg, which is equivalent to one full 5 mL ampule of the 0.8% solution. In many clinical scenarios, particularly when the goal is simply to visualize the ureteral orifices during surgery, a smaller dose of 20 mg (2.5 mL) may be sufficient. The maximum recommended dose for a single diagnostic procedure is typically 40 mg, although in rare cases involving prolonged surgeries or repeated assessments, a second dose may be administered at the discretion of the surgeon and anesthesiologist. The medication is usually given via slow intravenous injection to minimize the risk of sudden blood pressure changes.

Indigo is not commonly used in pediatric populations, and its safety and effectiveness in children have not been established through large-scale clinical trials. However, in specific pediatric urological cases, a physician may determine that the diagnostic benefit outweighs the potential risks. In such instances, the dose is strictly weight-based. A common pediatric guideline, though not officially FDA-labeled for all ages, is approximately 0.1 mg/kg to 0.2 mg/kg. Because of the lack of robust data, Indigo should be used in children only when absolutely necessary and under the direct supervision of a pediatric specialist.

Renal Impairment

In patients with known renal impairment (kidney disease), the excretion of Indigo will be significantly delayed. While a dosage adjustment (reduction) is not always required, the interpreting physician must account for the fact that the 'blue flush' may take much longer than the standard 5-15 minutes to appear. In cases of severe renal failure, the dye may not appear at all, rendering the test non-diagnostic.

Hepatic Impairment

Since Indigo is primarily excreted by the kidneys and undergoes minimal liver metabolism, no specific dosage adjustments are typically required for patients with liver disease. However, overall patient stability should be assessed before administration.

Elderly Patients

Elderly patients are more likely to have decreased renal function and a higher prevalence of cardiovascular disease. Because Indigo can cause a transient increase in blood pressure (pressor effect), it should be used with extreme caution in the elderly. Lower doses may be considered, and continuous blood pressure monitoring is essential.

Indigo is never self-administered by a patient. It is an injectable medication administered by a healthcare professional, usually an anesthesiologist or a surgeon.

• Preparation: The medical professional will inspect the ampule for any crystals or sediment. If crystals are present, the ampule may be slightly warmed to redissolve them.
• Administration: The dye is most commonly injected into a pre-existing intravenous line. It should be injected slowly.
• Storage: Ampules should be stored at room temperature (20°C to 25°C) and protected from light, as the dye is light-sensitive and can degrade over time.

Because Indigo is used as a one-time diagnostic tool during a specific medical procedure, the concept of a 'missed dose' in the traditional sense does not apply. If the dye is not administered during the procedure as planned, the surgeon will use alternative methods to visualize the anatomy or assess kidney function.

An overdose of Indigo is extremely rare because the medication is administered by professionals in controlled environments. However, if an excessive amount were given, the primary concerns would be:

• Severe Hypertension: A significant and sudden spike in blood pressure.
• Bradycardia: A dangerously slow heart rate.
• Skin Discoloration: The patient's skin may take on a temporary blue or dusky hue.

In the event of an overdose, treatment is supportive. The short half-life of the drug means that symptoms usually resolve quickly as the kidneys clear the dye. Emergency measures would include blood pressure management and cardiac monitoring.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to adjust or influence your dose without medical guidance. Always inform your doctor of any history of high blood pressure or heart disease before receiving Indigo.

Because Indigo is a diagnostic dye, many of its 'side effects' are actually expected results of the drug's presence in the body. The most common experience is discoloration of the urine. Patients should expect their urine to appear blue, green, or blue-green for 12 to 24 hours following the procedure. This is not harmful and will resolve as the drug is fully excreted.

Another common occurrence is a transient increase in blood pressure. Studies have shown that a significant percentage of patients experience a rise in systolic and diastolic blood pressure shortly after the injection. This is often accompanied by a slight decrease in heart rate (bradycardia). In healthy individuals, these changes are usually mild and go unnoticed, but they are closely monitored by the anesthesia team during surgery.

• Skin Discoloration: Some patients may notice a temporary blue or 'ashy' tint to their skin or mucous membranes (like the inside of the mouth). This occurs when the dye is circulating in high concentrations in the peripheral blood vessels.

Indigo (Indigotindisulfonate Sodium) is a potent diagnostic tool, but it is not without risks. The most critical safety point for patients to understand is that Indigo can cause sudden changes in cardiovascular stability. Because it can act as a mild vasoconstrictor (narrowing the blood vessels), it can cause a rapid rise in blood pressure. Patients with a history of heart disease, hypertension, or heart rhythm disorders must be extra vigilant. Additionally, because it is a dye, it can interfere with certain monitoring equipment used during surgery, potentially giving false readings of oxygen levels in the blood.

As of 2026, there are no FDA black box warnings for Indigo. It is considered a relatively safe diagnostic agent when used by trained professionals who can monitor the patient's vital signs in real-time.

• Allergic Reactions / Anaphylaxis Risk: Although rare, life-threatening allergic reactions have been reported. Patients who have a known allergy to any synthetic dyes (including those used in food or other medications) must inform their doctor. Anaphylaxis can occur even if the patient has never been exposed to Indigo before.

While there are no drugs that are strictly 'contraindicated' in a way that would cause a fatal chemical reaction, Indigo should not be used simultaneously with other diagnostic dyes like Methylene Blue unless specifically directed by a specialist. Combining dyes can make it impossible to distinguish between them and increases the risk of cardiovascular side effects and interference with pulse oximetry.

• Antihypertensive Medications: Since Indigo can raise blood pressure, it may temporarily counteract the effects of blood pressure-lowering drugs like Lisinopril, Amlodipine, or Metoprolol. The medical team may need to adjust the patient's blood pressure management during the procedure.
• MAO Inhibitors (MAOIs): Drugs used for depression (e.g., Phenelzine, Selegiline) can increase the body's sensitivity to pressor agents. While not a common interaction, there is a theoretical risk that Indigo could cause a more severe hypertensive spike in patients taking MAOIs.

Indigo (Indigotindisulfonate Sodium) must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity: If a patient has a documented allergy to Indigotindisulfonate Sodium or any other components of the injection, the drug is strictly contraindicated. An allergic reaction could lead to fatal anaphylaxis.
2. 2Severe, Uncontrolled Hypertension: Because Indigo has a known pressor effect that raises blood pressure, administering it to a patient who is already in a hypertensive crisis could lead to immediate complications like a stroke, heart attack, or acute heart failure.
3. 3Known Sensitivity to Synthetic Dyes: Patients who have had severe reactions to other FD&C dyes (like Blue No. 2) should not receive Indigo, as these are chemically related.

Indigo is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women. It is unknown whether Indigo can cause fetal harm when administered to a pregnant woman or if it can affect reproduction capacity. In clinical practice, Indigo is only used during pregnancy if the physician determines that the diagnostic benefit to the mother significantly outweighs the potential risk to the fetus. For example, if a pregnant woman requires emergency abdominal surgery and ureteral identification is critical to prevent surgical injury, the dye may be used. There is no evidence of teratogenicity (birth defects), but caution is the standard.

It is not known whether Indigotindisulfonate Sodium is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Indigo is administered to a nursing woman. Given the drug's very short half-life (under 10 minutes), it is cleared from the mother's bloodstream very quickly. Many clinicians suggest that 'pumping and discarding' breast milk for 12 to 24 hours after the procedure is a sufficient precaution to ensure the infant is not exposed to the dye.

Indigo (Indigotindisulfonate Sodium) functions as a biological marker. Its molecular mechanism is not based on binding to specific receptors to alter cell signaling. Instead, it is a highly water-soluble, sulfonated indigo dye that remains in the intravascular space until it reaches the kidneys. Once in the kidneys, it is rapidly filtered by the glomeruli and, more importantly, actively secreted by the proximal tubule cells into the tubular lumen. This concentrated presence in the urine provides the deep blue color necessary for visualization. The 'pressor effect' (increased blood pressure) is thought to be caused by a mild alpha-adrenergic stimulatory effect or a direct effect on vascular smooth muscle, though the exact molecular pathway for this side effect is not fully elucidated.

The pharmacodynamic effect of Indigo is almost entirely visual. The onset of action (appearance of blue urine) occurs within 5 to 15 minutes after IV injection. The duration of the effect depends on the patient's hydration status and renal function but typically lasts for 30 to 60 minutes of 'peak' blue color. The cardiovascular effects (increased BP) are usually immediate (within 1-2 minutes of injection) and transient, typically resolving within 10-15 minutes as the drug is redistributed and excreted.